Projects IrsiCaixa is involved in a hundred national and international research projects active each year, funded by both public and private entities. Breadcrumb Home Keywords Research group - Any -Cell Virology and Immunology (VIC)Immunology (IGG)Microbial Genomics (GEM)Neoantigens and Vaccines against Cancer (NeoVaCan)Pathogen Immunity, Signalling and Therapeutic Applications (PISTA)Retrovirology and Clinical Studies (GREC)T-cell Immunology and Vaccines (TIV)Tissue Virology (VITI)Translational Research in Immunology and Ageing (TRIA)Viral Immune Evasion and Vaccines (VIRIEVAC)Virus-Host Interactions (ViHIT) Researcher - Any -Aleix Elizalde TorrentAlejandro Riquelme GrauAlessandra BorgognoneAlex Olvera van der StoepAmaya Blanco PereraAnaí Villanueva DelgadoAnna López PlanaAnna Pons GrifolsArnau Creus OrodeaBeatriz Mothe PujadasBenjamin TrinitéBonaventura Clotet SalaCarla Rovirosa MartíCarlos Ávila NietoCarmen Aguilar GurrieriCecilia Cabrera NavarroChristian BranderCristina Benitez RodríguezCristina GálvezCristina Mesa RealCristina Peligero CruzCristina Ramírez SotoCristina Saiz MasvidalDàlia Raïch ReguéEdurne García VidalEdwards Pradenas SaavedraElena Lapaz LorenzoElisabet Fernández RosasElisabet García RodríguezElisabet Pallarés Elisa Molina MolinaEloi Franco Trepat Erola Ainsua EnrichEster Ballana GuixEudald Felip FalgàsEudald Vehí PiquéEulalia Grau SegúEva Armendariz BurgoaEva Riveira MuñozFernando Laguía NuedaFerran Abancó i EspugaFrancesc Català MollFrancesc Cunyat ViaplanaFrancisco M. Muñoz LópezGabriel Felipe Rodríguez LozanoGerard Campos GonzalezGooya BanaeiGustavo Rodríguez EstebanIgnasi Calba IñiguezIgor Moraes CardosoIrene González NavarroItziar Erkizia JauregiJacopo Faranda CordellaJakub ChojnackiJavier Martínez-PicadoJoan Pagès OliverasJon Izquierdo PujolJordi Senserrich VelascoJorge Carrillo MolinaJosé Luis Pérez GuillamónJudith Dalmau MorenoJulia García PradoJulià Blanco ArbuésJulián Eslava CampoJúlia Albó DelgadoLaia Bernad RosaLaia Vives AdriánLaura Planells FerrerLidia Garrido SanzLidia Ruiz TabuencaLluís Revilla SanchoLourdes Grau ParéLucía Gómez EspadaMacedonia Trigueros PeñaManel Garcia de la FuenteMarc Noguera i JulianMaria Casadellà FontdevilaMaria Nevot BanúsMaria Salgado BernalMarina Martinez VelascoMarina Matilla MartínezMarina Pino CebriánMariona Parera SallentMarissa Flores SantamaríaMarta Massanella LunaMarta Ruiz RiolMaría Lázaro DíezMiguel Ángel Martínez de la SierraMireia Martínez GameroMª Carmen García GuerreroMª Carmen Puertas CastroMª Luisa Rodríguez de la ConcepciónNatàlia Marrugat VilaNel Marín SánchezNuria Izquierdo UserosNúria de la Iglesia ZaragozaNúria Pedreño LópezOriol Careta BorràsPatricia Piñol JuradoPatricia Resa InfantePenélope Riquelme NevadoRafaela Ayen AparicioRaúl Pérez CaballeroRita Casas CostaRoger Badia CórcolesRoger ParedesRosina Malagrida EscalasRuth Peña PoderósRytis BoreikaSamandhy Cedeño BriceñoSandra Franco CireraSara Cabrero de las HerasSara Morón LópezSilvia Marfil VerchiliSonia Bange SinghSonia Villanueva HernándezSusana Esteban RayaSílvia Ribó GenéTeresa Puig OlivaTetyana PidkovaThuong NguyenTuixent Escribà BelValentina Triviño VenceVíctor Urrea GalesÁngel Bayón Gil From date To date Assess the immunomodulatory effect of leriglitazone on macrophages exposed to SARS-CoV-2 or to LPS Project status Ongoing Start/End 2023 / 2025 Principal investigator Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Global infectious diseases Financing entity Minoryx Therapeutics SL Thermal disinfection by magnetic induction: a study with SARS-CoV-2 pseudoviruses Project status Ongoing Start/End 2023 / 2025 Principal investigator Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Global infectious diseases Financing entity Fundació Institut Català de Nanociència i Nanotecnologia RBD Dimer recombinant protein vaccine against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Marta Ruiz Riol Julià Blanco Arbués Christian Brander Jorge Carrillo Molina Samandhy Cedeño Briceño Julia García Prado Nuria Izquierdo Useros Tuixent Escribà Bel Eulalia Grau Segú Beatriz Mothe Pujadas Personal investigador extern Èlia Torroella Strategic lines Cancer Emerging infectious diseases Financing entity European Commission Codi: 101046118 In vitro antiviral screening of compounds provided by Pharma Mar on Ebola virus entry and on the replication of HIV-1, Zika and SARS-CoV-2 Project status Ongoing Start/End 2021 / 2022 Principal investigator Ester Ballana Guix Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity PharmaMar New antiviral and immunomodulatory therapies against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity Spanish Ministry of Science and Innovation Assessment of the antiviral activity against SARS-CoV-2 of certain mouthwashes Project status Ongoing Start/End 2021 / 2022 Principal investigator Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity DENTAID S.L. Novel antiviral approaches against SARS-CoV-2 Project status Ongoing Start/End 2020 / 2021 Principal investigator Nuria Izquierdo Useros Strategic lines Cancer Emerging infectious diseases Financing entity Dentaid Novel inhibitors of the inflammasome for the mitigation of SARS-CoV-2 pathogenic effects in human type II pneumocytes and transgenic mouse models Project status Ongoing Start/End 2020 / 2021 Principal investigator Nuria Izquierdo Useros Personal investigador extern Timothy Thomson Okatsu Participating entities Consejo Superior de Investigaciones Científicas (CSIC), Institut d'Investigacions Biomèdiques de Barcelona IIBB (Barcelona), Mount Sinai-Icahn School of Medicine (New York) Strategic lines Cancer Emerging infectious diseases Financing entity Proyectos de investigación sobre el SARS-CoV-2 y la enfermedad COVID19 del ISCIII Glycoengineering nanovehicles to purge viral reservoirs Project status Ongoing Start/End 2018 / 2021 Principal investigator Nuria Izquierdo Useros Participating entities ICN2 and Biofisika-CISC Financing entity Spanish Ministry of Economy and Competitiveness, ref. SAF2017-91767-EXP. Fostering prophylactic and therapeutic strategies to fight the SARS-CoV-2 pandemic Project status Ongoing Start/End 2020 / 2022 Principal investigator Bonaventura Clotet Sala Julià Blanco Arbués Jorge Carrillo Molina Nuria Izquierdo Useros Personal investigador extern Joquim Segalés, Julia Vergara-Alert, Alfonso Valencia, Victor Guallard Participating entities Barcelona Supercomputing Center (BSC), Animal Health Research Center (IRTA-CReSA) Financing entity Grifols Pagination 1 Page 2 Next Last
Assess the immunomodulatory effect of leriglitazone on macrophages exposed to SARS-CoV-2 or to LPS Project status Ongoing Start/End 2023 / 2025 Principal investigator Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Global infectious diseases Financing entity Minoryx Therapeutics SL
Thermal disinfection by magnetic induction: a study with SARS-CoV-2 pseudoviruses Project status Ongoing Start/End 2023 / 2025 Principal investigator Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Global infectious diseases Financing entity Fundació Institut Català de Nanociència i Nanotecnologia
RBD Dimer recombinant protein vaccine against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Marta Ruiz Riol Julià Blanco Arbués Christian Brander Jorge Carrillo Molina Samandhy Cedeño Briceño Julia García Prado Nuria Izquierdo Useros Tuixent Escribà Bel Eulalia Grau Segú Beatriz Mothe Pujadas Personal investigador extern Èlia Torroella Strategic lines Cancer Emerging infectious diseases Financing entity European Commission Codi: 101046118
In vitro antiviral screening of compounds provided by Pharma Mar on Ebola virus entry and on the replication of HIV-1, Zika and SARS-CoV-2 Project status Ongoing Start/End 2021 / 2022 Principal investigator Ester Ballana Guix Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity PharmaMar
New antiviral and immunomodulatory therapies against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity Spanish Ministry of Science and Innovation
Assessment of the antiviral activity against SARS-CoV-2 of certain mouthwashes Project status Ongoing Start/End 2021 / 2022 Principal investigator Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity DENTAID S.L.
Novel antiviral approaches against SARS-CoV-2 Project status Ongoing Start/End 2020 / 2021 Principal investigator Nuria Izquierdo Useros Strategic lines Cancer Emerging infectious diseases Financing entity Dentaid
Novel inhibitors of the inflammasome for the mitigation of SARS-CoV-2 pathogenic effects in human type II pneumocytes and transgenic mouse models Project status Ongoing Start/End 2020 / 2021 Principal investigator Nuria Izquierdo Useros Personal investigador extern Timothy Thomson Okatsu Participating entities Consejo Superior de Investigaciones Científicas (CSIC), Institut d'Investigacions Biomèdiques de Barcelona IIBB (Barcelona), Mount Sinai-Icahn School of Medicine (New York) Strategic lines Cancer Emerging infectious diseases Financing entity Proyectos de investigación sobre el SARS-CoV-2 y la enfermedad COVID19 del ISCIII
Glycoengineering nanovehicles to purge viral reservoirs Project status Ongoing Start/End 2018 / 2021 Principal investigator Nuria Izquierdo Useros Participating entities ICN2 and Biofisika-CISC Financing entity Spanish Ministry of Economy and Competitiveness, ref. SAF2017-91767-EXP.
Fostering prophylactic and therapeutic strategies to fight the SARS-CoV-2 pandemic Project status Ongoing Start/End 2020 / 2022 Principal investigator Bonaventura Clotet Sala Julià Blanco Arbués Jorge Carrillo Molina Nuria Izquierdo Useros Personal investigador extern Joquim Segalés, Julia Vergara-Alert, Alfonso Valencia, Victor Guallard Participating entities Barcelona Supercomputing Center (BSC), Animal Health Research Center (IRTA-CReSA) Financing entity Grifols